✨ Medicine Distribution Consents




NEW ZEALAND GAZETTE, No. 95

5 AUGUST 2010

Product: Glimaccord
Active Ingredient: Glimepiride 1mg
Dosage Form: Tablet
New Zealand Sponsor: Accord Healthcare NZ Limited
Manufacturer: Intas Pharmaceuticals Limited, Ahmedabad, India

Product: Glimaccord
Active Ingredient: Glimepiride 2mg
Dosage Form: Tablet
New Zealand Sponsor: Accord Healthcare NZ Limited
Manufacturer: Intas Pharmaceuticals Limited, Ahmedabad, India

Product: Glimaccord
Active Ingredient: Glimepiride 3mg
Dosage Form: Tablet
New Zealand Sponsor: Accord Healthcare NZ Limited
Manufacturer: Intas Pharmaceuticals Limited, Ahmedabad, India

Product: Glimaccord
Active Ingredient: Glimepiride 4mg
Dosage Form: Tablet
New Zealand Sponsor: Accord Healthcare NZ Limited
Manufacturer: Intas Pharmaceuticals Limited, Ahmedabad, India

Product: Lamisil Foot & Body
Active Ingredient: Terbinafine hydrochloride 10mg
Dosage Form: Topical cream
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturers: Novartis Consumer Health SA, Nyon, Switzerland
Novartis Pharma Produktions GmbH, Wehr, Germany

Product: Piax
Active Ingredient: Clopidogrel bisulfate 97.9mg equivalent to 75mg clopidogrel base
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Pharmaceuticals Inc, West Virginia, United States of America

Dated this 30th day of July 2010.

STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5966

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Lamisil
Active Ingredient: Terbinafine hydrochloride 10mg/g equivalent to 8.8mg terbinafine
Dosage Form: Topical solution
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturers: Novartis Pharma AG, Basel, Switzerland
Novartis Pharma SAS, Huningue, France

Product: Solox
Active Ingredient: Lansoprazole 15mg
Dosage Form: Capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Liconsa SA, Guadalajara, Spain

Dated this 30th day of July 2010.

STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5967



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 95





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
30 July 2010
Medicines, Glimaccord, Lamisil Foot & Body, Piax, Glimepiride, Terbinafine hydrochloride, Clopidogrel bisulfate
  • STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
30 July 2010
Medicines, Lamisil, Solox, Terbinafine hydrochloride, Lansoprazole
  • STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health